Skip to main content
Premium Trial:

Request an Annual Quote

Don Bailey

OncoCyte said in a document filed with the US Securities and Exchange Commission that Don Bailey has tendered his resignation from its board of directors. The firm will recruit a new independent director to fill his spot. No reason was given for his departure. Baily has been on OncoCyte's board since August. He was president and CEO of Questcor Pharmaceuticals from 2007 to 2014. From 1991 to 2000, he was CEO of Comarco, where he also served as its chairman of the board from 1998 to 2007. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.